Partners Diana Watral and Rebecca Fitzpatrick Honored as 2025 “Notable Litigators and Trial Attorneys” by Crain’s Chicago

Crain’s Chicago Business recognized Kirkland partners Diana Watral and Rebecca Fitzpatrick among its 2025 “Notable Litigators and Trial Attorneys,” a list honoring those who “advocate for clients in complex disputes and influence legal developments nationwide.”

Diana, who represents pharmaceutical companies in multidistrict litigation, class actions and False Claims Act cases, was recognized for serving as lead counsel for Eli Lilly in insulin pricing litigation.

Rebecca’s practice focuses on fact- and science-intensive commercial, mass tort and product liability litigation, class actions, and complex disputes. She was recognized for defending Abbott Laboratories in an infant formula case.